nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—Injection site haematoma—Octreotide—thymus cancer	0.0458	0.0573	CcSEcCtD
Risperidone—Liver fatty—Octreotide—thymus cancer	0.0344	0.0431	CcSEcCtD
Risperidone—HTR2A—phrenic nerve—thymus cancer	0.0315	0.157	CbGeAlD
Risperidone—Breast pain female—Octreotide—thymus cancer	0.0297	0.0372	CcSEcCtD
Risperidone—Oligomenorrhoea—Octreotide—thymus cancer	0.0279	0.0349	CcSEcCtD
Risperidone—Faeces discoloured—Octreotide—thymus cancer	0.0249	0.0311	CcSEcCtD
Risperidone—HTR7—pulmonary artery—thymus cancer	0.0184	0.0913	CbGeAlD
Risperidone—HTR7—vein—thymus cancer	0.0167	0.0831	CbGeAlD
Risperidone—Hepatic steatosis—Octreotide—thymus cancer	0.0143	0.0179	CcSEcCtD
Risperidone—Diabetic—Octreotide—thymus cancer	0.0129	0.0162	CcSEcCtD
Risperidone—Pruritus generalised—Octreotide—thymus cancer	0.0129	0.0162	CcSEcCtD
Risperidone—Breast feeding—Octreotide—thymus cancer	0.0123	0.0155	CcSEcCtD
Risperidone—Clotting—Octreotide—thymus cancer	0.0121	0.0151	CcSEcCtD
Risperidone—HTR2A—pulmonary artery—thymus cancer	0.0115	0.057	CbGeAlD
Risperidone—Hypochromic anaemia—Octreotide—thymus cancer	0.0111	0.0139	CcSEcCtD
Risperidone—Hepatitis cholestatic—Octreotide—thymus cancer	0.0107	0.0134	CcSEcCtD
Risperidone—HTR2A—vein—thymus cancer	0.0104	0.0518	CbGeAlD
Risperidone—Ear infection—Octreotide—thymus cancer	0.0101	0.0127	CcSEcCtD
Risperidone—Ulcerative stomatitis—Octreotide—thymus cancer	0.00934	0.0117	CcSEcCtD
Risperidone—Sinus bradycardia—Octreotide—thymus cancer	0.00879	0.011	CcSEcCtD
Risperidone—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0082	0.0103	CcSEcCtD
Risperidone—Renal pain—Octreotide—thymus cancer	0.0082	0.0103	CcSEcCtD
Risperidone—Ear disorder—Octreotide—thymus cancer	0.00799	0.01	CcSEcCtD
Risperidone—Pregnancy—Octreotide—thymus cancer	0.0076	0.00951	CcSEcCtD
Risperidone—Cholecystitis—Octreotide—thymus cancer	0.00751	0.0094	CcSEcCtD
Risperidone—Haemorrhoids—Octreotide—thymus cancer	0.00734	0.00918	CcSEcCtD
Risperidone—Transaminases increased—Octreotide—thymus cancer	0.00709	0.00887	CcSEcCtD
Risperidone—Cholelithiasis—Octreotide—thymus cancer	0.00694	0.00868	CcSEcCtD
Risperidone—Haematoma—Octreotide—thymus cancer	0.00686	0.00859	CcSEcCtD
Risperidone—Hypothyroidism—Octreotide—thymus cancer	0.00672	0.00841	CcSEcCtD
Risperidone—Galactorrhoea—Octreotide—thymus cancer	0.00665	0.00832	CcSEcCtD
Risperidone—Redness—Octreotide—thymus cancer	0.00639	0.008	CcSEcCtD
Risperidone—Intestinal obstruction—Octreotide—thymus cancer	0.00633	0.00792	CcSEcCtD
Risperidone—Paranoia—Octreotide—thymus cancer	0.00633	0.00792	CcSEcCtD
Risperidone—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00633	0.00792	CcSEcCtD
Risperidone—Menstrual disorder—Octreotide—thymus cancer	0.00633	0.00792	CcSEcCtD
Risperidone—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.00627	0.00784	CcSEcCtD
Risperidone—H1F0—neck—thymus cancer	0.00615	0.0306	CbGeAlD
Risperidone—Influenza-like symptoms—Octreotide—thymus cancer	0.00604	0.00756	CcSEcCtD
Risperidone—Metrorrhagia—Octreotide—thymus cancer	0.00604	0.00756	CcSEcCtD
Risperidone—Coagulopathy—Octreotide—thymus cancer	0.00554	0.00693	CcSEcCtD
Risperidone—Otitis media—Octreotide—thymus cancer	0.00554	0.00693	CcSEcCtD
Risperidone—Injection site pain—Octreotide—thymus cancer	0.00528	0.00661	CcSEcCtD
Risperidone—Numbness—Octreotide—thymus cancer	0.0052	0.00651	CcSEcCtD
Risperidone—Endocrine disorder—Octreotide—thymus cancer	0.0052	0.00651	CcSEcCtD
Risperidone—Acne—Octreotide—thymus cancer	0.00513	0.00642	CcSEcCtD
Risperidone—Sensory loss—Octreotide—thymus cancer	0.00498	0.00623	CcSEcCtD
Risperidone—Breast pain—Octreotide—thymus cancer	0.00494	0.00619	CcSEcCtD
Risperidone—Amenorrhoea—Octreotide—thymus cancer	0.00491	0.00614	CcSEcCtD
Risperidone—Rectal haemorrhage—Octreotide—thymus cancer	0.00478	0.00598	CcSEcCtD
Risperidone—Viral infection—Octreotide—thymus cancer	0.00478	0.00598	CcSEcCtD
Risperidone—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00474	0.00594	CcSEcCtD
Risperidone—Cellulitis—Octreotide—thymus cancer	0.00474	0.00594	CcSEcCtD
Risperidone—Arthropathy—Octreotide—thymus cancer	0.00474	0.00594	CcSEcCtD
Risperidone—H1F0—hematopoietic system—thymus cancer	0.00458	0.0228	CbGeAlD
Risperidone—Hearing impaired—Octreotide—thymus cancer	0.00453	0.00567	CcSEcCtD
Risperidone—Muscle twitching—Octreotide—thymus cancer	0.00439	0.0055	CcSEcCtD
Risperidone—Vaginal inflammation—Octreotide—thymus cancer	0.00431	0.0054	CcSEcCtD
Risperidone—Injection site reaction—Octreotide—thymus cancer	0.00429	0.00537	CcSEcCtD
Risperidone—Eructation—Octreotide—thymus cancer	0.00424	0.0053	CcSEcCtD
Risperidone—Cystitis noninfective—Octreotide—thymus cancer	0.00421	0.00527	CcSEcCtD
Risperidone—Wheezing—Octreotide—thymus cancer	0.00419	0.00524	CcSEcCtD
Risperidone—Influenza like illness—Octreotide—thymus cancer	0.00419	0.00524	CcSEcCtD
Risperidone—Cystitis—Octreotide—thymus cancer	0.00416	0.00521	CcSEcCtD
Risperidone—Vaginal infection—Octreotide—thymus cancer	0.00407	0.0051	CcSEcCtD
Risperidone—Cramps of lower extremities—Octreotide—thymus cancer	0.00396	0.00496	CcSEcCtD
Risperidone—Mouth ulceration—Octreotide—thymus cancer	0.0039	0.00488	CcSEcCtD
Risperidone—Urine output increased—Octreotide—thymus cancer	0.0039	0.00488	CcSEcCtD
Risperidone—Bladder pain—Octreotide—thymus cancer	0.0039	0.00488	CcSEcCtD
Risperidone—Gynaecomastia—Octreotide—thymus cancer	0.00386	0.00483	CcSEcCtD
Risperidone—HTR7—neck—thymus cancer	0.00379	0.0189	CbGeAlD
Risperidone—Hyperkinesia—Octreotide—thymus cancer	0.00376	0.00471	CcSEcCtD
Risperidone—Phlebitis—Octreotide—thymus cancer	0.00363	0.00455	CcSEcCtD
Risperidone—Sleep disorder—Octreotide—thymus cancer	0.00362	0.00453	CcSEcCtD
Risperidone—Thrombophlebitis—Octreotide—thymus cancer	0.00362	0.00453	CcSEcCtD
Risperidone—Diabetes mellitus—Octreotide—thymus cancer	0.0036	0.00451	CcSEcCtD
Risperidone—Polyuria—Octreotide—thymus cancer	0.00357	0.00446	CcSEcCtD
Risperidone—Gastroenteritis—Octreotide—thymus cancer	0.00353	0.00442	CcSEcCtD
Risperidone—Deafness—Octreotide—thymus cancer	0.0035	0.00438	CcSEcCtD
Risperidone—H1F0—cardiac atrium—thymus cancer	0.00347	0.0173	CbGeAlD
Risperidone—Nasal congestion—Octreotide—thymus cancer	0.00344	0.0043	CcSEcCtD
Risperidone—H1F0—pituitary gland—thymus cancer	0.00339	0.0169	CbGeAlD
Risperidone—Amnesia—Octreotide—thymus cancer	0.00333	0.00417	CcSEcCtD
Risperidone—Anaphylactoid reaction—Octreotide—thymus cancer	0.00323	0.00405	CcSEcCtD
Risperidone—H1F0—lymphoid tissue—thymus cancer	0.00322	0.016	CbGeAlD
Risperidone—Arthritis—Octreotide—thymus cancer	0.00322	0.00403	CcSEcCtD
Risperidone—Hypoglycaemia—Octreotide—thymus cancer	0.00321	0.00402	CcSEcCtD
Risperidone—Osteoarthritis—Octreotide—thymus cancer	0.00313	0.00392	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00313	0.00392	CcSEcCtD
Risperidone—Pain in extremity—Octreotide—thymus cancer	0.00313	0.00392	CcSEcCtD
Risperidone—Psychotic disorder—Octreotide—thymus cancer	0.00306	0.00383	CcSEcCtD
Risperidone—HTR1A—hematopoietic system—thymus cancer	0.00295	0.0147	CbGeAlD
Risperidone—H1F0—bone marrow—thymus cancer	0.00293	0.0146	CbGeAlD
Risperidone—H1F0—thyroid gland—thymus cancer	0.00293	0.0146	CbGeAlD
Risperidone—Dehydration—Octreotide—thymus cancer	0.00291	0.00364	CcSEcCtD
Risperidone—Dry skin—Octreotide—thymus cancer	0.00287	0.00359	CcSEcCtD
Risperidone—Abdominal pain upper—Octreotide—thymus cancer	0.00286	0.00358	CcSEcCtD
Risperidone—HTR7—hematopoietic system—thymus cancer	0.00282	0.014	CbGeAlD
Risperidone—Nasopharyngitis—Octreotide—thymus cancer	0.0028	0.0035	CcSEcCtD
Risperidone—Gastritis—Octreotide—thymus cancer	0.00277	0.00347	CcSEcCtD
Risperidone—Muscular weakness—Octreotide—thymus cancer	0.00276	0.00346	CcSEcCtD
Risperidone—Abdominal distension—Octreotide—thymus cancer	0.00272	0.00341	CcSEcCtD
Risperidone—ADRA1A—hematopoietic system—thymus cancer	0.00272	0.0135	CbGeAlD
Risperidone—Influenza—Octreotide—thymus cancer	0.00271	0.00339	CcSEcCtD
Risperidone—Asthma—Octreotide—thymus cancer	0.00271	0.00339	CcSEcCtD
Risperidone—Bronchospasm—Octreotide—thymus cancer	0.00266	0.00333	CcSEcCtD
Risperidone—H1F0—lung—thymus cancer	0.00266	0.0132	CbGeAlD
Risperidone—Pancreatitis—Octreotide—thymus cancer	0.00265	0.00332	CcSEcCtD
Risperidone—Sweating increased—Octreotide—thymus cancer	0.00264	0.0033	CcSEcCtD
Risperidone—KCNH2—hematopoietic system—thymus cancer	0.00263	0.0131	CbGeAlD
Risperidone—Bronchitis—Octreotide—thymus cancer	0.0026	0.00326	CcSEcCtD
Risperidone—Abdominal discomfort—Octreotide—thymus cancer	0.00259	0.00325	CcSEcCtD
Risperidone—HTR7—epithelium—thymus cancer	0.00258	0.0128	CbGeAlD
Risperidone—Dysuria—Octreotide—thymus cancer	0.00253	0.00317	CcSEcCtD
Risperidone—Upper respiratory tract infection—Octreotide—thymus cancer	0.00251	0.00315	CcSEcCtD
Risperidone—Pollakiuria—Octreotide—thymus cancer	0.0025	0.00313	CcSEcCtD
Risperidone—ADRA1A—epithelium—thymus cancer	0.00249	0.0124	CbGeAlD
Risperidone—Weight increased—Octreotide—thymus cancer	0.00246	0.00308	CcSEcCtD
Risperidone—Weight decreased—Octreotide—thymus cancer	0.00245	0.00306	CcSEcCtD
Risperidone—Hyperglycaemia—Octreotide—thymus cancer	0.00244	0.00306	CcSEcCtD
Risperidone—Pneumonia—Octreotide—thymus cancer	0.00243	0.00304	CcSEcCtD
Risperidone—Drowsiness—Octreotide—thymus cancer	0.00241	0.00302	CcSEcCtD
Risperidone—Depression—Octreotide—thymus cancer	0.00241	0.00301	CcSEcCtD
Risperidone—HTR2A—neck—thymus cancer	0.00237	0.0118	CbGeAlD
Risperidone—Neuropathy peripheral—Octreotide—thymus cancer	0.00237	0.00296	CcSEcCtD
Risperidone—Jaundice—Octreotide—thymus cancer	0.00235	0.00294	CcSEcCtD
Risperidone—Conjunctivitis—Octreotide—thymus cancer	0.00235	0.00294	CcSEcCtD
Risperidone—Urinary tract infection—Octreotide—thymus cancer	0.00235	0.00294	CcSEcCtD
Risperidone—Haematuria—Octreotide—thymus cancer	0.0023	0.00288	CcSEcCtD
Risperidone—Hepatobiliary disease—Octreotide—thymus cancer	0.00228	0.00286	CcSEcCtD
Risperidone—Epistaxis—Octreotide—thymus cancer	0.00228	0.00285	CcSEcCtD
Risperidone—Sinusitis—Octreotide—thymus cancer	0.00226	0.00283	CcSEcCtD
Risperidone—Bradycardia—Octreotide—thymus cancer	0.0022	0.00276	CcSEcCtD
Risperidone—CYP3A5—hematopoietic system—thymus cancer	0.00217	0.0108	CbGeAlD
Risperidone—Rhinitis—Octreotide—thymus cancer	0.00217	0.00272	CcSEcCtD
Risperidone—Hepatitis—Octreotide—thymus cancer	0.00217	0.00271	CcSEcCtD
Risperidone—Hypoaesthesia—Octreotide—thymus cancer	0.00216	0.0027	CcSEcCtD
Risperidone—Pharyngitis—Octreotide—thymus cancer	0.00215	0.00269	CcSEcCtD
Risperidone—Oedema peripheral—Octreotide—thymus cancer	0.00213	0.00267	CcSEcCtD
Risperidone—HTR2B—thyroid gland—thymus cancer	0.00211	0.0105	CbGeAlD
Risperidone—HRH1—hematopoietic system—thymus cancer	0.00211	0.0105	CbGeAlD
Risperidone—Visual impairment—Octreotide—thymus cancer	0.00209	0.00261	CcSEcCtD
Risperidone—ADRA2A—hematopoietic system—thymus cancer	0.00207	0.0103	CbGeAlD
Risperidone—Tinnitus—Octreotide—thymus cancer	0.00202	0.00253	CcSEcCtD
Risperidone—Cardiac disorder—Octreotide—thymus cancer	0.00201	0.00252	CcSEcCtD
Risperidone—Flushing—Octreotide—thymus cancer	0.00201	0.00252	CcSEcCtD
Risperidone—KCNH2—cardiac atrium—thymus cancer	0.002	0.00994	CbGeAlD
Risperidone—DRD2—pituitary gland—thymus cancer	0.00198	0.00985	CbGeAlD
Risperidone—ADRA2C—cardiac atrium—thymus cancer	0.00197	0.0098	CbGeAlD
Risperidone—Immune system disorder—Octreotide—thymus cancer	0.00196	0.00245	CcSEcCtD
Risperidone—KCNH2—pituitary gland—thymus cancer	0.00195	0.00971	CbGeAlD
Risperidone—Arrhythmia—Octreotide—thymus cancer	0.00193	0.00242	CcSEcCtD
Risperidone—HRH1—epithelium—thymus cancer	0.00193	0.00959	CbGeAlD
Risperidone—ADRA2C—pituitary gland—thymus cancer	0.00193	0.00958	CbGeAlD
Risperidone—ADRA1A—lymphoid tissue—thymus cancer	0.00192	0.00954	CbGeAlD
Risperidone—HTR2B—lung—thymus cancer	0.00192	0.00953	CbGeAlD
Risperidone—Alopecia—Octreotide—thymus cancer	0.00191	0.0024	CcSEcCtD
Risperidone—Mental disorder—Octreotide—thymus cancer	0.0019	0.00238	CcSEcCtD
Risperidone—Erythema—Octreotide—thymus cancer	0.00189	0.00236	CcSEcCtD
Risperidone—Malnutrition—Octreotide—thymus cancer	0.00189	0.00236	CcSEcCtD
Risperidone—Flatulence—Octreotide—thymus cancer	0.00186	0.00233	CcSEcCtD
Risperidone—Tension—Octreotide—thymus cancer	0.00185	0.00232	CcSEcCtD
Risperidone—Nervousness—Octreotide—thymus cancer	0.00183	0.00229	CcSEcCtD
Risperidone—Back pain—Octreotide—thymus cancer	0.00182	0.00228	CcSEcCtD
Risperidone—H1F0—lymph node—thymus cancer	0.00182	0.00904	CbGeAlD
Risperidone—Muscle spasms—Octreotide—thymus cancer	0.00181	0.00227	CcSEcCtD
Risperidone—Vision blurred—Octreotide—thymus cancer	0.00178	0.00222	CcSEcCtD
Risperidone—Tremor—Octreotide—thymus cancer	0.00177	0.00221	CcSEcCtD
Risperidone—HTR2A—hematopoietic system—thymus cancer	0.00176	0.00876	CbGeAlD
Risperidone—Ill-defined disorder—Octreotide—thymus cancer	0.00175	0.00219	CcSEcCtD
Risperidone—Anaemia—Octreotide—thymus cancer	0.00174	0.00218	CcSEcCtD
Risperidone—Agitation—Octreotide—thymus cancer	0.00173	0.00217	CcSEcCtD
Risperidone—Malaise—Octreotide—thymus cancer	0.0017	0.00213	CcSEcCtD
Risperidone—Vertigo—Octreotide—thymus cancer	0.00169	0.00212	CcSEcCtD
Risperidone—Syncope—Octreotide—thymus cancer	0.00169	0.00212	CcSEcCtD
Risperidone—KCNH2—bone marrow—thymus cancer	0.00169	0.00839	CbGeAlD
Risperidone—Palpitations—Octreotide—thymus cancer	0.00167	0.00209	CcSEcCtD
Risperidone—Loss of consciousness—Octreotide—thymus cancer	0.00166	0.00207	CcSEcCtD
Risperidone—Cough—Octreotide—thymus cancer	0.00165	0.00206	CcSEcCtD
Risperidone—HTR7—lung—thymus cancer	0.00164	0.00816	CbGeAlD
Risperidone—Convulsion—Octreotide—thymus cancer	0.00163	0.00204	CcSEcCtD
Risperidone—CYP3A4—hematopoietic system—thymus cancer	0.00163	0.00811	CbGeAlD
Risperidone—Hypertension—Octreotide—thymus cancer	0.00163	0.00204	CcSEcCtD
Risperidone—HTR2A—epithelium—thymus cancer	0.00161	0.00801	CbGeAlD
Risperidone—Chest pain—Octreotide—thymus cancer	0.00161	0.00201	CcSEcCtD
Risperidone—Myalgia—Octreotide—thymus cancer	0.00161	0.00201	CcSEcCtD
Risperidone—Arthralgia—Octreotide—thymus cancer	0.00161	0.00201	CcSEcCtD
Risperidone—CYP2D6—hematopoietic system—thymus cancer	0.0016	0.00798	CbGeAlD
Risperidone—Anxiety—Octreotide—thymus cancer	0.0016	0.002	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00159	0.002	CcSEcCtD
Risperidone—Discomfort—Octreotide—thymus cancer	0.00159	0.00199	CcSEcCtD
Risperidone—ADRA2A—cardiac atrium—thymus cancer	0.00157	0.00782	CbGeAlD
Risperidone—Dry mouth—Octreotide—thymus cancer	0.00157	0.00196	CcSEcCtD
Risperidone—DRD2—lung—thymus cancer	0.00155	0.00771	CbGeAlD
Risperidone—Oedema—Octreotide—thymus cancer	0.00154	0.00193	CcSEcCtD
Risperidone—Anaphylactic shock—Octreotide—thymus cancer	0.00154	0.00193	CcSEcCtD
Risperidone—ADRA2A—pituitary gland—thymus cancer	0.00154	0.00764	CbGeAlD
Risperidone—Infection—Octreotide—thymus cancer	0.00153	0.00191	CcSEcCtD
Risperidone—Shock—Octreotide—thymus cancer	0.00151	0.00189	CcSEcCtD
Risperidone—Nervous system disorder—Octreotide—thymus cancer	0.00151	0.00189	CcSEcCtD
Risperidone—ADRA2C—lung—thymus cancer	0.00151	0.0075	CbGeAlD
Risperidone—Thrombocytopenia—Octreotide—thymus cancer	0.00151	0.00189	CcSEcCtD
Risperidone—Tachycardia—Octreotide—thymus cancer	0.0015	0.00188	CcSEcCtD
Risperidone—Skin disorder—Octreotide—thymus cancer	0.00149	0.00187	CcSEcCtD
Risperidone—Hyperhidrosis—Octreotide—thymus cancer	0.00149	0.00186	CcSEcCtD
Risperidone—Anorexia—Octreotide—thymus cancer	0.00147	0.00184	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0014	0.00175	CcSEcCtD
Risperidone—Insomnia—Octreotide—thymus cancer	0.00139	0.00174	CcSEcCtD
Risperidone—Paraesthesia—Octreotide—thymus cancer	0.00138	0.00173	CcSEcCtD
Risperidone—Dyspnoea—Octreotide—thymus cancer	0.00137	0.00172	CcSEcCtD
Risperidone—Somnolence—Octreotide—thymus cancer	0.00137	0.00171	CcSEcCtD
Risperidone—Dyspepsia—Octreotide—thymus cancer	0.00135	0.0017	CcSEcCtD
Risperidone—Decreased appetite—Octreotide—thymus cancer	0.00134	0.00167	CcSEcCtD
Risperidone—Gastrointestinal disorder—Octreotide—thymus cancer	0.00133	0.00166	CcSEcCtD
Risperidone—Fatigue—Octreotide—thymus cancer	0.00133	0.00166	CcSEcCtD
Risperidone—ADRA2A—thyroid gland—thymus cancer	0.00132	0.00659	CbGeAlD
Risperidone—Pain—Octreotide—thymus cancer	0.00132	0.00165	CcSEcCtD
Risperidone—Constipation—Octreotide—thymus cancer	0.00132	0.00165	CcSEcCtD
Risperidone—HTR2B—lymph node—thymus cancer	0.00131	0.00652	CbGeAlD
Risperidone—HTR2A—pituitary gland—thymus cancer	0.00131	0.0065	CbGeAlD
Risperidone—Feeling abnormal—Octreotide—thymus cancer	0.00127	0.00159	CcSEcCtD
Risperidone—CYP3A5—lung—thymus cancer	0.00126	0.00628	CbGeAlD
Risperidone—Gastrointestinal pain—Octreotide—thymus cancer	0.00126	0.00157	CcSEcCtD
Risperidone—HRH1—lung—thymus cancer	0.00122	0.00609	CbGeAlD
Risperidone—Urticaria—Octreotide—thymus cancer	0.00122	0.00153	CcSEcCtD
Risperidone—Abdominal pain—Octreotide—thymus cancer	0.00122	0.00152	CcSEcCtD
Risperidone—Body temperature increased—Octreotide—thymus cancer	0.00122	0.00152	CcSEcCtD
Risperidone—ADRA2A—lung—thymus cancer	0.0012	0.00598	CbGeAlD
Risperidone—ABCB1—hematopoietic system—thymus cancer	0.00115	0.00574	CbGeAlD
Risperidone—Hypersensitivity—Octreotide—thymus cancer	0.00113	0.00142	CcSEcCtD
Risperidone—Asthenia—Octreotide—thymus cancer	0.0011	0.00138	CcSEcCtD
Risperidone—Pruritus—Octreotide—thymus cancer	0.00109	0.00136	CcSEcCtD
Risperidone—ABCB1—epithelium—thymus cancer	0.00105	0.00525	CbGeAlD
Risperidone—Diarrhoea—Octreotide—thymus cancer	0.00105	0.00132	CcSEcCtD
Risperidone—KCNH2—lymph node—thymus cancer	0.00104	0.0052	CbGeAlD
Risperidone—ADRA2C—lymph node—thymus cancer	0.00103	0.00513	CbGeAlD
Risperidone—HTR2A—lung—thymus cancer	0.00102	0.00509	CbGeAlD
Risperidone—Dizziness—Octreotide—thymus cancer	0.00102	0.00127	CcSEcCtD
Risperidone—Vomiting—Octreotide—thymus cancer	0.000978	0.00122	CcSEcCtD
Risperidone—Rash—Octreotide—thymus cancer	0.00097	0.00121	CcSEcCtD
Risperidone—Dermatitis—Octreotide—thymus cancer	0.000969	0.00121	CcSEcCtD
Risperidone—Headache—Octreotide—thymus cancer	0.000964	0.00121	CcSEcCtD
Risperidone—Nausea—Octreotide—thymus cancer	0.000914	0.00114	CcSEcCtD
Risperidone—ABCB1—pituitary gland—thymus cancer	0.000856	0.00426	CbGeAlD
Risperidone—HRH1—lymph node—thymus cancer	0.000838	0.00417	CbGeAlD
Risperidone—ADRA2A—lymph node—thymus cancer	0.000823	0.00409	CbGeAlD
Risperidone—ABCB1—lymphoid tissue—thymus cancer	0.000812	0.00404	CbGeAlD
Risperidone—ABCB1—bone marrow—thymus cancer	0.00074	0.00368	CbGeAlD
Risperidone—ABCB1—thyroid gland—thymus cancer	0.000738	0.00367	CbGeAlD
Risperidone—ABCB1—lung—thymus cancer	0.00067	0.00333	CbGeAlD
Risperidone—ABCB1—lymph node—thymus cancer	0.000458	0.00228	CbGeAlD
